Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 40% decrease from the number of companies cited in the previous year.
Of the 68 citations issued, the most common citation was 'Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been established'.
Most of the companies cited were involved in the Food and Cosmetics sector. The second most common type of company cited in the time period worked in the the Devices sector.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
A. M. Surgical, Inc. | Devices | 10/20/2023 | DMR - not or inadequately maintained |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Specifications - identity, purity, strength, composition |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Specifications met - identity, purity, strength, composition |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Component - verify identity, dietary ingredient |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Quality control - reject; specification not met |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Standard reference materials; criteria for selecting |
Abel & Schafer, Inc. | Food and Cosmetics | 01/25/2023 | Equipment and utensils - Design and maintenance |
Ackermann Usa, Inc. | Devices | 08/04/2023 | Lack of or inadequate receiving acceptance procedures |
Ackermann Usa, Inc. | Devices | 08/04/2023 | Lack of or inadequate complaint procedures |
All Star Specialties Corporation | Food and Cosmetics | 02/22/2023 | Plant operations - Precautions |
Banyan USA, LLC | Devices | 09/12/2023 | Lack of Written MDR Procedures |
Banyan USA, LLC | Devices | 09/12/2023 | Management review - defined interval, sufficient frequency |
Banyan USA, LLC | Devices | 09/12/2023 | Quality Audit/Reaudit - conducted |
Banyan USA, LLC | Devices | 09/12/2023 | Lack of procedures, or not maintained |
Banyan USA, LLC | Devices | 09/12/2023 | Documented evaluation |
Banyan USA, LLC | Devices | 09/12/2023 | Maintenance schedule, Lack of or inadequate schedule |
Banyan USA, LLC | Devices | 09/12/2023 | Documentation |
Banyan USA, LLC | Devices | 09/12/2023 | Incoming acceptance records, documentation |
Banyan USA, LLC | Devices | 09/12/2023 | Lack of or inadequate complaint procedures |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | HACCP plan implementation |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Food safety hazards |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Critical limits |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Verification procedures - adequacy |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Signed and dated |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Corrective action per predetermined plan |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Verification - record review - frequency |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Sanitation monitoring |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Importer verification |
Due Amici Imports, Inc. | Food and Cosmetics | 03/23/2023 | Develop FSVP |
G Fuel, LLC | Food and Cosmetics | 07/05/2023 | Quality control - required operations product complaints |
G Fuel, LLC | Food and Cosmetics | 07/05/2023 | Quality control operations - tests, examinations; results |
In Store Distributors, Inc. | Food and Cosmetics | 03/21/2023 | Manufacturing, processing, packing, holding - Controls |
La Ricura Foods, Ltd. | Food and Cosmetics | 08/21/2023 | Develop FSVP |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Procedure Deviations Recorded and Justified |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Actual vs. theoretical yields not determined |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Strict control not exercised over labeling issued |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Storage under appropriate conditions |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Labeling Control Records and Label Copies |
Mirion Technologies | Devices | 02/10/2023 | Document change records, maintained. |
Mirion Technologies | Devices | 02/10/2023 | DHR - not or inadequately maintained |
Muscle Sport Products, LLC | Food and Cosmetics | 05/09/2023 | Written procedures - quality control operations |
New York Blood Center Enterprises | Biologics | 12/22/2023 | Following manufacturer's instructions |
New York Blood Center Enterprises | Biologics | 12/22/2023 | Establish, maintain and follow manufacturing SOPs |
New York Blood Center Enterprises | Biologics | 12/22/2023 | Person performing, test results, interpretation |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Procedures not in writing, fully followed |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | GMP Training Frequency |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Equipment Design, Size and Location |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Written procedures not established/followed |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Component identity verification |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Absence of Written Procedures |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Expiration date lacking |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Record maintenance 1 year (except exempt OTC) |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Records reviewed annually |
Red Medical Solutions, Inc. | Devices | 03/22/2023 | Lack of or inadequate procedures |
Red Medical Solutions, Inc. | Devices | 03/22/2023 | Lack of or inadequate complaint procedures |
Sleep Joy International, LLC | Devices | 01/20/2023 | Lack of Written MDR Procedures |
Sleep Joy International, LLC | Devices | 01/20/2023 | Quality System Procedures |
Sleep Joy International, LLC | Devices | 01/20/2023 | Design Validation - Risk analysis not performed/inadequate |
Sleep Joy International, LLC | Devices | 01/20/2023 | Design history file |
Spirit Pharmaceuticals | Drugs | 11/01/2023 | Computer control of master formula records |
Spirit Pharmaceuticals | Drugs | 11/01/2023 | Reports of Analysis (Components) |
Spirit Pharmaceuticals | Drugs | 11/01/2023 | Lack of written stability program |
Stony Brook University Medical Center | Biologics | 02/07/2023 | Establish, maintain and follow manufacturing SOPs |
Stony Brook University Medical Center | Biologics | 02/07/2023 | Required records |
Stony Brook University Medical Center | Biologics | 02/07/2023 | Biological product deviation report |
W. A. Baum Company, Inc. | Devices | 11/06/2023 | Lack of Written MDR Procedures |
W. A. Baum Company, Inc. | Devices | 11/06/2023 | Evaluation of suppliers, contractors, etc., requirements |
W. A. Baum Company, Inc. | Devices | 11/06/2023 | Documentation |